Literature DB >> 5637563

Long-term results of DC reversion of atrial fibrillation.

M D Radford, D W Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5637563      PMCID: PMC514683          DOI: 10.1136/hrt.30.1.91

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  19 in total

1.  "CARDIOVERSION" OF ARRHYTHMIAS. II.

Authors:  B LOWN
Journal:  Mod Concepts Cardiovasc Dis       Date:  1964-08

2.  A CLINICAL APPRAISAL OF ATRIAL TRANSPORT FUNCTION.

Authors:  H B BURCHELL
Journal:  Lancet       Date:  1964-04-11       Impact factor: 79.321

3.  THE PROGNOSIS OF ATRIAL FIBRILLATION FOLLOWING MITRAL VALVOTOMY.

Authors:  V R BLOOM
Journal:  Br Heart J       Date:  1963-09

4.  DIRECT-CURRENT SHOCK IN TREATMENT OF DRUG-RESISTANT CARDIAC ARRHYTHMIAS.

Authors:  L MCDONALD; L RESNEKOV; K O'BRIEN
Journal:  Br Med J       Date:  1964-06-06

5.  SUCCESSFUL USE OF EXTERNAL ELECTRICAL CARDIOVERSION IN THE TREATMENT OF VENTRICULAR FIBRILLATION CAUSED BY QUINIDINE.

Authors:  G A RUBEIZ; M EL-HAJJ; A TOUMA
Journal:  Am J Cardiol       Date:  1965-07       Impact factor: 2.778

6.  DIGITALIS INTOXICATION FOLLOWING CONVERSION TO SINUS RHYTHM.

Authors:  R GILBERT; R P CUDDY
Journal:  Circulation       Date:  1965-07       Impact factor: 29.690

7.  Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

Authors:  R E BALL; M SOKOLOW
Journal:  Circulation       Date:  1956-10       Impact factor: 29.690

8.  Paroxysmal ventricular tachycardia and fibrillation due to quinidine.

Authors:  M J BINDER; L ROSOVE
Journal:  Am J Med       Date:  1952-04       Impact factor: 4.965

9.  Significance of ventricular and pseudoventricular arrhythmias appearing after D.C. countershock.

Authors:  A Castellanos; L Lemberg; E J Fonseca
Journal:  Am Heart J       Date:  1965-11       Impact factor: 4.749

10.  Direct current conversion of atrial fibrillation.

Authors:  P B Halmos
Journal:  Br Heart J       Date:  1966-05
View more
  13 in total

1.  Quinidine before direct current countershock. A controlled study.

Authors:  L Hillestad; J Dale; O Storstein
Journal:  Br Heart J       Date:  1972-02

2.  Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate.

Authors:  E Byrne-Quinn; A J Wing
Journal:  Br Heart J       Date:  1970-05

Review 3.  [Physiopathology and pathophysiology of excitation in the human heart. Findings in electrotherapy of heart rhythm disturbances].

Authors:  M Büchner
Journal:  Arch Kreislaufforsch       Date:  1969 Nov-Dec

4.  [Blood level studies on the most suitable dosage forms in long-term quinidine therapy].

Authors:  H Zettner; D Michel
Journal:  Klin Wochenschr       Date:  1971-05

5.  Electroversion of lone atrial fibrillation and flutter including haemodynamic studies at rest and on exercise.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1971-05

6.  Electrical cardioversion for persistent atrial fibrillation after treatment of thyrotoxicosis.

Authors:  P Emery; J S Staffurth
Journal:  Postgrad Med J       Date:  1982-12       Impact factor: 2.401

7.  Comparison of lidoflazine and quindine in prophylactic treatment of arrhythmias.

Authors:  B M Kennelly
Journal:  Br Heart J       Date:  1977-05

8.  Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine.

Authors:  J F Gunning; A Kristinsson; G Miller; K Saunders
Journal:  Br Heart J       Date:  1970-07

9.  Persistent lone atrial fibrillation--its prognosis after clinical diagnosis.

Authors:  J B Close; D W Evans; S M Bailey
Journal:  J R Coll Gen Pract       Date:  1979-09

10.  Quinidine for pharmacological cardioversion of atrial fibrillation: a retrospective analysis in 501 consecutive patients.

Authors:  Bernhard Schwaab; Alexander Katalinic; Uta Maria Böge; Jürgen Loh; Peter Blank; Tatjana Kölzow; Dirk Poppe; Hendrik Bonnemeier
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.